Lataa...
CD4(+) T-helper Type 1 Cytokines and Trastuzumab Facilitate CD8(+) T-cell Targeting of HER-2/neu-expressing Cancers
Vaccination strategies incorporating the immunodominant HLA-A2-restricted HER2/neu-derived peptide 369-377 (HER2(369-377)) are increasingly utilized in HER2/neu-expressing cancer patients. The failure of post-vaccination HER2(369-377)-specific CD8(+) T cells to recognize HLA-A2(pos)HER2/neu-expressi...
Tallennettuna:
| Julkaisussa: | Cancer Immunol Res |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556111/ https://ncbi.nlm.nih.gov/pubmed/25791067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0208 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|